EFFECTIVENESS OF TREATMENT FOR AUTONOMIC DYSFUNCTION AND QUALITY OF LIFE CHANGES IN PARKINSON’S DISEASE PATIENTS
Main Article Content
Abstract
Background: Autonomic dysfunction is a common non-motor manifestation of Parkinson’s disease, which markedly impairs quality of life and increases the risks of falls, hospitalization, and mortality. However, in Vietnam, studies evaluating the effectiveness of treatments for autonomic dysfunction remain limited. Objectives: To evaluate treatment effectiveness for autonomic dysfunction and its impact on quality of life in Parkinson’s disease patients.Materials and Methods: A prospective observational study was conducted on 54 patients with Parkinson’s disease and autonomic dysfunction treated at Can Tho Central General Hospital between 2023 and 2025. Results: The median PDQ-8 score decreased from 9 to 5 after 3 months. SCOPA-AUT and OHQ scores showed significant reductions over time, most prominently in patients with orthostatic hypotension. Conclusions: Comprehensive management of Parkinson’s disease combined with appropriate treatment of autonomic dysfunction significantly improves quality of life and non-motor symptoms.
Keywords
Parkinson’s disease, autonomic dysfunction, quality of life, PDQ-8, SCOPA-AUT
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
2. Zhou Z, Zhang X, et al. Characteristics of autonomic dysfunction in Parkinson's disease: a large Chinese multicenter cohort study. Front Aging Neurosci. 2021. 13, 680045. doi:10.3389/fnagi.2021.680045.
3. Võ Nguyễn Ngọc Trang, Nguyễn Hữu Công, Trần Công Thắng. Đánh giá mức độ rối loạn thần kinh tự chủ trên bệnh Parkinson và teo đa hệ thống. Luận án Tiến sĩ Y học. Đại học Y Dược TP.HCM. 2022.
4. Nguyễn Thị Thùy Linh, Nguyễn Thị Kim Liên, Nguyễn Thanh Bình. Rối loạn nuốt và một số yếu tố liên quan trên bệnh nhân Parkinson giai đoạn muộn. Tạp chí Y học Việt Nam. 2022. 519(1). https://doi.org/10.51298/vmj.v519i1.3527.
5. Nguyễn Thị Bích Lệ, Nguyễn Văn Liệu. Một số triệu chứng ngoài vận động ở người bệnh Parkinson giai đoạn trung bình và nặng. Tạp chí Y học Việt Nam. 2024. 533(1), 156–161. https://doi.org/10.51298/vmj.v533i1.7733.
6. Diep DT, Le VM, et al. Levodopa and pramipexole combination therapy efficacy in Vietnamese patients with Parkinson’s disease: a randomized controlled trial. Russian Open Medical Journal. 2024. 13(1), 0101. doi:10.15275/rusomj.2024.0101.
7. Palma JA, Thijs RD. Non-Pharmacological Treatment of Autonomic Dysfunction in Parkinson’s Disease and Other Synucleinopathies. J Parkinsons Dis. 2024. 14(S1), S81–S92. doi:10.3233/JPD-223593.
8. Stewart CB, Lang AE, et al. The longitudinal progression of autonomic dysfunction in Parkinson's disease: a 7-year study. Front Neurol. 2023. 14, 1134562. doi:10.3389/fneur.2023.1134562.
9. Velseboer DC, de Haan RJ, et al. Prevalence of orthostatic hypotension in Parkinson’s disease: A systematic review and meta-analysis. Parkinsonism Relat Disord. 2011. 17(10), 724–729. doi:10.1016/j.parkreldis.2011.06.009.
10. Merola A, Romagnolo A, et al. Autonomic dysfunction in Parkinson's disease: A prospective cohort study. Mov Disord. 2018. 33(3), 391–397. doi:10.1002/mds.27147.